Drug Testing and Adherence Monitoring in Substance Abuse Patients

  • Steven Michael Lampert
  • Alan David Kaye
  • Richard D. Urman
  • Laxmaiah Manchikanti

Abstract

A Russian proverb was espoused by former president Ronald Regan in the 1980s in negotiations with the Soviet leadership, “Trust, but verify.” This same concept has been adopted by many physicians working with patients on chronic opioid therapy. Physicians that prescribe chronic opioid therapy have an ethical and legal responsibility to monitor for treatment adherence. One way to enhance the trust between the prescribing physician and the patient is to implement a comprehensive adherence-monitoring program.

Keywords

Drug testing Adherence monitoring Substance abuse Prescription drug monitoring programs Stratification of risk Pill counts An algorithmic approach 

References

  1. 1.
    Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15:S67–116.PubMedGoogle Scholar
  2. 2.
    Manchikanti L, Boswell MV, Hirsch JA. Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs. Expert Rev Neurother. 2013;13:527–43.PubMedCrossRefGoogle Scholar
  3. 3.
    Christo PJ, Manchikanti L, Ruan X, Bottros M, Hansen H, Solanki D, Jordan AE, Colson J. Urine drug testing in chronic pain. Pain Physician. 2011;14:123–43.PubMedGoogle Scholar
  4. 4.
    Atluri SL, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence-based approach. Pain Physician. 2012;15:ES177–89.PubMedGoogle Scholar
  5. 5.
    Manchikanti L, Helm II S, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician. 2012;15:ES9–38.PubMedGoogle Scholar
  6. 6.
    Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10–3.Google Scholar
  7. 7.
    Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–92.Google Scholar
  8. 8.
    Kuehn BM. Prescription drug abuse rises globally. JAMA. 2007;297:1306.PubMedGoogle Scholar
  9. 9.
    Report of the International Narcotics Control Board for 2011. United Nations, New York; 2011. www.unodc.org/documents/southasia/reports/2011_INCB_ANNUAL_REPORT_english_PDF.pdf.
  10. 10.
    The Use of Medicines in the United States: review of 2011. Report by the IMS Institute for Healthcare Informatics. www.imshealth.com.
  11. 11.
    Inocencio TJ, Carroll NV, Read EJ, Holdford DA. The economic burden of opioid-related poisoning in the United States. Pain Med. 2013. doi: 10.1111/pme.12183 [Epub ahead of print].PubMedGoogle Scholar
  12. 12.
    Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRefGoogle Scholar
  13. 13.
    Chou R, Fanciullo GJ, Fine PG, et al. American Pain Society—American Academy of Pain Medicine Opioids guidelines panel; clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009;10:113–30.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Centers for Disease Control and Prevention. Prescription drug overdose: state law. http://www.cdc.gov/HomeandRecreationalSafety/poisoning/laws/index.html.
  15. 15.
    Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56:19–23.PubMedCrossRefGoogle Scholar
  16. 16.
    Solanki DR, Koyyalagunta D, Shah RV, Silverman SM, Manchikanti L. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician. 2011;14:E119–31.PubMedGoogle Scholar
  17. 17.
    Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15:ES67–92.PubMedGoogle Scholar
  18. 18.
    Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005;8:335–47.PubMedGoogle Scholar
  19. 19.
    Goodin A, Blumenschein K, Freeman PR, Talbert J. Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population. Pain Physician. 2012;15:ES169–75.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Drug Enforcement Administration and the National Alliance for Model State Drug Laws. A closer look at state prescription monitoring programs. http://www.deadiversion.usdoj.gov/pubs/program/prescription-monitor/summary.htm.
  21. 21.
    Nafziger AN, Bertino Jr JS. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009;25(1):73–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Standridge JB, Adams SM, Zotos AP. Drug screening: a valuable office procedure. Am Fam Physician. 2010;81:635–40.PubMedGoogle Scholar
  23. 23.
    Michna E, Jamison RN, Pham LD, Ross EL, Janfaza D, Nedeljkovic SS, Narang S, Palombi D, Wasan AD. Toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23:173–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Manchikanti L, Malla Y, Wargo BW, Fellows B. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Pain Physician. 2011;14:175–87.PubMedGoogle Scholar
  25. 25.
    Manchikanti L, Malla Y, Wargo BW, Fellows B. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing. Pain Physician. 2011;14:259–70.PubMedGoogle Scholar
  26. 26.
    Manchikanti L, Hirsch JA. The pains of chronic opioid usage [Spotlight]. AHRQ WebM&M [serial online]. September 2013.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Steven Michael Lampert
    • 1
  • Alan David Kaye
    • 2
  • Richard D. Urman
    • 1
  • Laxmaiah Manchikanti
    • 3
  1. 1.Department of Anesthesiology, Perioperative and Pain MedicineBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Departments of Anesthesiology and PharmacologyLouisiana State University Health Sciences Center Louisiana State University Interim Hospital, and Ochsner Kenner HospitalNew OrleansUSA
  3. 3.Anesthesiology and Perioperative MedicineUniversity of Louisville, KentuckyPaducahUSA

Personalised recommendations